Disclosure: Some of the links on this page are affiliate links. Clicking these and making a purchase will directly support Rekkerd. Thanks!

Musicrow releases Ebola, updated Reaktor ensemble now available separately


Musicrow has announced that its Ebola Reaktor ensemble is now available to purchase separately.

Ebola is a powerful semi-modular virtual analog synthesizer with a flexible architecture, that enables you to create a wide variety of sounds with a distinct flavor! Ebola that was updated with a new look and extra sounds, contains now more than 300 high quality presets for instant use.

Musicrow Group Ebola

Ebola features

  • A library more than 300 high quality sounds, divided into 7 sound banks.
  • Two multimode oscillators with Ring modulation, Sync, and Frequency modulation..
  • Classic mode that enables you to shape your oscillator waveform by morphing between many different waveforms.
  • Ultrasaw mode that uses up to 9 detuned saw-tooth waves, for the creation of extremely thick leads and pads.
  • Wavetable synthesis mode helps you achieving evolving and interesting pad sounds, organs and keyboards.
  • Sub-oscillator with ultrasaw mode.
  • Noise generator with color shaping option.
  • Two multimode resonant filters that can be connected in parallel or serial.
  • Three envelopes that can modulate almost any parameter of the synthesizer.
  • Advanced distortion section for wave-shaping: Analog saturation, Hard Clipping, Bit Crusher and more..
  • Two advanced LFO’s.
  • Extended effects section that contains 9 high quality effects: Delay, Reverb, Chorus, Phaser, distortion, EQ, ring modulation and others.
  • Modulation matrix with countless modulation paths.
  • Envelope follower that enables you to use external audio to manipulate almost any parameter of the synthesizer.

Ebola for Reaktor 5 is now available to purchase for 39 EUR. It is also included in the The Golden Ensembles 2 bundle for 119 EUR. Prices excl. VAT.

More information: Musicrow Group / Ebola

Notify of
Inline Feedbacks
View all comments